Table: Kyorin Pharmaceutical -2024/25 group results

Kyorin Pharmaceutical

12/05/2025 07:32

May 12 (Reuters)- 
          Kyorin Pharmaceutical Co., Ltd. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2025    Mar 31, 2024   Mar 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          130.09          119.53         127.00        57.40    
               (+8.8 pct)      (+5.5 pct)     (-2.4 pct)    (+4.1 pct) 
  Operating       12.57            6.23           6.10         1.70    
              (+101.6 pct)                    (-51.5 pct)   (+9.7 pct) 
  Recurring       13.22            6.82           6.30         1.80    
               (+93.8 pct)                    (-52.3 pct)  (-12.2 pct) 
  Net
  Net              9.09            5.48           4.80         1.40    
               (+66.0 pct)                    (-47.2 pct)  (+11.5 pct) 
  EPS          158.17 yen       95.41 yen      83.55 yen    24.37 yen  
  Ann Div       57.00 yen       52.00 yen      57.00 yen               
  -Q2 Div       20.00 yen       20.00 yen      20.00 yen               
  -Q4 Div       37.00 yen       32.00 yen      37.00 yen               
  
  NOTE - Kyorin Pharmaceutical Co., Ltd..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4569.T